For the first time, UCL researchers have used AI to identify two biologically distinct forms of multiple sclerosis, supporting the potential for more personalised care and improved treatment decisions for patients worldwide.
NICE recommends natalizumab, including a lower-cost biosimilar, as a new treatment for adults with highly active relapsing-remitting multiple sclerosis, expanding options for thousands of patients.
Representatives of the Association of British Neurologists advisory group for MS and neuroinflammation discuss the role of neuroinflammation in both neurodegenerative diseases like multiple sclerosis (MS) and the ageing process.
The UK’s Horizon trial will test a vaccine against the Epstein-Barr virus (EBV), linked to multiple sclerosis, aiming to train the immune system and explore a potential new treatment for MS.
Researchers at the University of Nottingham have used a lightweight, wearable OPM‑MEG brain scanner to uncover distinct brain‐function changes in people with Multiple Sclerosis, a non‑invasive advance that could improve diagnosis and tracking of disease progression.
A UK patient has become the first with multiple sclerosis (MS) to receive cutting-edge CAR T-cell therapy, as scientists test whether the one-time treatment can halt disease progression.
MS Australia is a national not-for-profit organisation dedicated to improving the lives of those affected by multiple sclerosis. Its remit includes supporting research for...
Advertisements
Latest Academic Articles
The latest academic articles from key research stakeholders
